Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

105
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
105
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.1K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.1K
Pharmacovigilance01:19

Pharmacovigilance

974
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
974
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

723
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
723
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

118
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
118
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

104
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
104

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Pharmacist Board Certification on Health Outcomes of Critically Ill Patients: An Analysis of the Optimizing Pharmacist-Team Integration for ICU Patient Management (OPTIM) Study.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Comment on "Rise of the Machines: Comparing Performance of Artificial Intelligence Large Language Models on Pharmacy Specialty Certification Examination Practice Questions".

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Don't stop the heart: a performance analysis of large language models and potassium dosing.

medRxiv : the preprint server for health sciences·2026
Same author

A Survey of Hospital Pharmacy Leader Perspectives on Advocating for Clinical Pharmacy Services.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

CNS1-dependent regulatory T cells shape recovery from acute lung injury.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Can AI Say "I Don't Know"?

The New England journal of medicine·2026

Related Experiment Video

Updated: Sep 5, 2025

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.4K

Reverse Triggering: An Introduction to Diagnosis, Management, and Pharmacologic Implications.

Brian Murray1, Andrea Sikora2, Jason R Mock1

  • 1University of North Carolina Hospitals, Chapel Hill, NC, United States.

Frontiers in Pharmacology
|July 11, 2022
PubMed
Summary
This summary is machine-generated.

Reverse triggering, a patient-ventilator asynchrony, occurs when a ventilator breath triggers patient effort. Deep sedation may increase risk, prompting consideration of reduced sedation or ventilator adjustments.

Keywords:
acute respiratory distress syndromecritical caremechanical ventilationrespiratory failurereverse triggeringsedation

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K
Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
06:51

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device

Published on: July 29, 2016

8.0K

Related Experiment Videos

Last Updated: Sep 5, 2025

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.4K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K
Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
06:51

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device

Published on: July 29, 2016

8.0K

Area of Science:

  • Critical Care Medicine
  • Respiratory Physiology
  • Pharmacology

Background:

  • Patient-ventilator asynchrony is a common complication in mechanically ventilated patients.
  • Reverse triggering, a specific type of asynchrony, involves unintended patient effort.
  • Understanding its physiology and consequences is crucial for patient management.

Purpose of the Study:

  • To review the current knowledge on reverse triggering.
  • To explore its pharmacotherapeutic implications and drug-device-patient interactions.
  • To summarize reported cases, physiology, epidemiology, and management strategies.

Main Methods:

  • A comprehensive literature search of the PubMed database was conducted.
  • Publications reporting patients with reverse triggering were identified and analyzed.
  • Key aspects including physiology, clinical presentation, and management were synthesized.

Main Results:

  • Deep sedation is identified as a potential predisposing factor for reverse triggering.
  • Initial management strategies may involve decreasing sedation levels or adjusting ventilator settings.
  • Limited evidence exists, highlighting the need for further research.

Conclusions:

  • Reverse triggering is an underdiagnosed condition with significant patient outcome implications.
  • Clinician awareness and further research are essential for effective management.
  • Optimizing sedation and ventilator settings are initial steps in addressing this asynchrony.